Delphinus Medical Technologies, LLC., is a Michigan company and a spin-off of the Barbara Ann Karmanos Cancer Institute (KCI). Delphinus has succeeded in building a three-dimensional full-breast ultrasound imaging device that effectively differentiates benign from malignant masses in breast cancer cases using a safe (non-ionizing), comfortable (non-compressing), and reliable (operator independent) patented technology. Utilizing multi-parametric ultrasound and sophisticated computer algorithms, rather than X-rays, SoftVue safely and comfortably screens women for breast cancer, assesses breast cancer risk, diagnoses breast diseases and monitors therapy.